Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy (Review)
- Authors:
- Ioana Rădulescu
- Ana Miruna Drăgoi
- Simona Corina Trifu
- Mihai Bogdan Cristea
-
Affiliations: Faculty of Psychology and Educational Sciences, University of Bucharest, 050663 Bucharest, Romania, Department of Psychiatry, ‘Prof. Dr. Alex. Obregia’ Clinical Hospital of Psychiatry, 041914 Bucharest, Romania, Department of Clinical Neurosciences, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania, Department of Morphological Sciences, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania - Published online on: August 5, 2021 https://doi.org/10.3892/etm.2021.10565
- Article Number: 1131
-
Copyright: © Rădulescu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
|
World Health Organization: Information on Mental Disorders. Available from: http://www.who.int/mental_health/management/depression/definition/en/index. | |
|
Zhang FF, Peng W, Sweeney JA, Jia ZY and Gong QY: Brain structure alterations in depression: Psychoradiological evidence. CNS Neurosci Ther. 24:994–1003. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Geerlings MI and Gerritsen L: Late-life depression, hippocampal volumes, and hypothalamic-pituitary-adrenal axis regulation: A systematic review and meta-analysis. Biol Psychiatry. 82:339–350. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Campbell S, Marriott M, Nahmias C and MacQueen GM: Lower hippocampal volume in patients suffering from depression: A meta-analysis. Am J Psychiatry. 161:598–607. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Eker C and Gonul AS: Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research. World J Biol Psychiatry. 11:19–35. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Trifu S: Neuroendocrine insights into burnout syndrome. Acta Endocrinol (Bucur). 15:404–405. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Srivastava S, Bhatia MS, Bhargava SK, Kumari R and Chandra S: A diffusion tensor imaging study using a voxel-based analysis, region-of-interest method to analyze white matter abnormalities in first-episode, treatment-naïve major depressive disorder. J Neuropsychiatry Clin Neurosci. 28:131–137. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Bora E, Fornito A, Pantelis C and Yücel M: Gray matter abnormalities in major depressive disorder: A meta-analysis of voxel based morphometry studies. J Affect Disord. 138:9–18. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Ramezani M, Abolmaesumi P, Tahmasebi A, Bosma R, Tong R, Hollenstein T, Harkness K and Johnsrude I: Fusion analysis of first episode depression: Where brain shape deformations meet local composition of tissue. Neuroimage Clin. 7:114–121. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Foland-Ross LC, Sacchet MD, Prasad G, Gilbert B, Thompson PM and Gotlib IH: Cortical thickness predicts the first onset of major depression in adolescence. Int J Dev Neurosci. 46:125–131. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Shen Z, Cheng Y, Yang S, Dai N, Ye J, Liu X, Lu J, Li N, Liu F, Lu Y, et al: Changes of grey matter volume in first-episode drug-naive adult major depressive disorder patients with different age-onset. Neuroimage Clin. 12:492–498. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kong L, Wu F, Tang Y, Ren L, Kong D, Liu Y, Xu K and Wang F: Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: A VBM-DARTEL study. PLoS One. 9(e79055)2014.PubMed/NCBI View Article : Google Scholar | |
|
Lu Y, Liang H, Han D, Mo Y, Li Z, Cheng Y, Xu X, Shen Z, Tan C, Zhao W, et al: The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder. Neuroimage Clin. 11:658–666. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhang H, Li L, Wu M, Chen Z, Hu X, Chen Y, Zhu H, Jia Z and Gong Q: Brain gray matter alterations in first episodes of depression: A meta-analysis of whole-brain studies. Neurosci Biobehav Rev. 60:43–50. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Jacobs RH, Barba A, Gowins JR, Klumpp H, Jenkins LM, Mickey BJ, Ajilore O, Peciña M, Sikora M, Ryan KA, et al: Decoupling of the amygdala to other salience network regions in adolescent-onset recurrent major depressive disorder. Psychol Med. 46:1055–1067. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Dombrovski AY, Siegle GJ, Szanto K, Clark L, Reynolds CF and Aizenstein H: The temptation of suicide: Striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med. 42:1203–1215. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Wagner G, Koch K, Schachtzabel C, Schultz CC, Sauer H and Schlösser RG: Structural brain alterations in patients with major depressive disorder and high risk for suicide: Evidence for a distinct neurobiological entity? Neuroimage. 54:1607–1614. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Forbes EE, Hariri AR, Martin SL, Silk JS, Moyles DL, Fisher PM, Brown SM, Ryan ND, Birmaher B, Axelson DA and Dahl RE: Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry. 166:64–73. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Yang XH, Wang Y, Huang J, Zhu CY, Liu XQ, Cheung EF, Xie GR and Chan RC: Increased prefrontal and parietal cortical thickness does not correlate with anhedonia in patients with untreated first-episode major depressive disorders. Psychiatry Res. 234:144–151. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Chen Z, Peng W, Sun H, Kuang W, Li W, Jia Z and Gong Q: High-field magnetic resonance imaging of structural alterations in first-episode, drug-naive patients with major depressive disorder. Transl Psychiatry. 6(e942)2016.PubMed/NCBI View Article : Google Scholar | |
|
Sliz D and Hayley S: Major depressive disorder and alterations in insular cortical activity: A review of current functional magnetic imaging research. Front Hum Neurosci. 6(323)2012.PubMed/NCBI View Article : Google Scholar | |
|
Lange C and Irle E: Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychol Med. 34:1059–1064. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Frodl T, Meisenzahl E, Zetzsche T, Bottlender R, Born C, Groll C, Jäger M, Leinsinger G, Hahn K and Möller HJ: Enlargement of the amygdala in patients with a first episode of major depression. Biol Psychiatry. 51:708–714. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST and Raichle ME: A functional anatomical study of unipolar depression. J Neurosci. 12:3628–3641. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Vyas A, Jadhav S and Chattarji S: Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala. Neuroscience. 143:387–393. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Abercrombie HC, Schaefer SM, Larson CL, Oakes TR, Lindgren KA, Holden JE, Perlman SB, Turski PA, Krahn DD, Benca RM and Davidson RJ: Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport. 9:3301–3307. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Conrad CD, LeDoux JE, Magariños AM and McEwen BS: Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 113:902–913. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Merzenich M: Soft-Wired: How the new science of brain plasticity can change your life. San Francisco: Parnassus Publishing, 2013. | |
|
Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn AM, Nordborg C, Peterson DA and Gage FH: Neurogenesis in the adult human hippocampus. Nat Med. 4:1313–1317. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Albert PR: Adult neuroplasticity: A new ‘cure’ for major depression? J Psychiatry Neurosci. 44:147–150. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 57:925–935. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Woolley CS, Gould E and McEwen BS: Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons. Brain Res. 531:225–231. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Duman RS: Depression: A case of neuronal life and death? Biol Psychiatry. 56:140–145. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Virgin CE Jr, Ha TP, Packan DR, Tombaugh GC, Yang SH, Horner HC and Sapolsky RM: Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: Implications for glucocorticoid neurotoxicity. J Neurochem. 57:1422–1428. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS and Morrison JH: Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience. 125:1–6. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Wellman CL: Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol. 49:245–253. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Radley JJ, Rocher AB, Rodriguez A, Ehlenberger DB, Dammann M, McEwen BS, Morrison JH, Wearne SL and Hof PR: Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J Comp Neurol. 507:1141–1150. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Furini C, Myskiw J and Izquierdo I: The learning of fear extinction. Neurosci Biobehav Rev. 47:670–683. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Izquierdo A, Wellman CL and Holmes A: Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci. 26:5733–5738. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Dibbets P, van den Broek A and Evers EA: Fear conditioning and extinction in anxiety- and depression-prone persons. Memory. 23:350–364. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, Silva JA, Tekell JL, Martin CC, Lancaster JL and Fox PT: Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry. 156:675–682. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Mutschler I, Ball T, Wankerl J and Strigo IA: Pain and emotion in the insular cortex: Evidence for functional reorganization in major depression. Neurosci Lett. 520:204–209. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA and Shulman GL: A default mode of brain function. Proc Natl Acad Sci USA. 98:676–682. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Jovanov E: On physiological bases of states of expanded in consciousness. In: State of consciousness. Experimental insights into meditation, walking, sleeping and dreams. Cvetkovic D and Cosic I (eds). Springer-Verlag Berlin Heidelberg, New York, NY, pp203-223, 2011. | |
|
Hamilton JP, Farmer M, Fogelman P and Gotlib IH: Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience. Biol Psychiatry. 78:224–230. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Williams LM: Precision psychiatry: A neural circuit taxonomy for depression and anxiety. Lancet Psychiatry. 3:472–480. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Dragoi AM, Radulescu I, Năsui BA, Pop AL, Varlas VN and Trifu S: Clozapine: An updated overview of pharmacogenetic biomarkers, risks, and safety-particularities in the context of COVID-19. Brain Sci. 10(840)2020.PubMed/NCBI View Article : Google Scholar | |
|
Pop AL, Crişan S, Bârcă M, Ciobanu AM, Varlas VN, Pop C, Pali MA, Cauni D, Ozon EA, Udeanu D, et al: Evaluation of dissolution profiles of a newly developed solid oral immediate-release formula containing alpha-lipoic acid. Processes. 9(176)2021. | |
|
Zarei M, Johansen-Berg H, Smith S, Ciccarelli O, Thompson AJ and Matthews PM: Functional anatomy of interhemispheric cortical connections in the human brain. J Anat. 209:311–320. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Serafini G: Neuroplasticity and major depression, the role of modern antidepressant drugs. World J Psychiatry. 2:49–57. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Popov VI, Bocharova LS and Bragin AG: Repeated changes of dendritic morphology in the hippocampus of ground squirrels in the course of hibernation. Neuroscience. 48:45–51. 1992.PubMed/NCBI View Article : Google Scholar | |
|
McEwen BS, Nasca C and Gray JD: Stress effects on neuronal structure: Hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 41:3–23. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Fuchs E: Neuroplasticity: A new approach to the pathophysiology of depression. In: Neuroplasticity: New biochemical mechanisms. Costa e Silva JA, Macher JP and Olie JP (eds). Springer, London, pp1-12, 2009. | |
|
Jay TM: Cellular plasticity and the pathophysiology of depression. In: Neuroplasticity: New Biochemical Mechanisms. Costa e Silva JA, Macher JP and Olie JP (eds). Springer, London, pp41-55, 2009. | |
|
Waløen K, Kleppe R, Martinezand A and Haavik J: Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease. Expert Opin Ther Targets. 21:167–180. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Peyrovian B, Rosenblat JD, Pan Z, Iacobucci M, Brietzke E and McIntyre RS: The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 92:387–404. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Saldanha D, Kumar N, Ryali V, Srivastava K and Pawar AA: Serum serotonin abnormality in depression. Med J Armed Forces India. 65:108–112. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Villas-Boas GR, Lavorato SN, Paes MM, de Carvalho PMG, Rescia VC, Cunha MS, de Magalhães-Filho MF, Ponsoni LF, de Carvalho AAV, de Lacerda RB, et al: Modulation of the serotonergic receptosome in the treatment of anxiety and depression: A narrative review of the experimental evidence. Pharmaceuticals (Basel). 14(148)2021.PubMed/NCBI View Article : Google Scholar | |
|
Tang L, Wang Y, Chen Y, Chen L, Zheng S, Bao M, Xiang J, Luo H, Li J and Li Y: The association between 5HT2A T102C and behavioral and psychological symptoms of dementia in Alzheimer's disease: A meta-analysis. Biomed Res Int. 2017(5320135)2017.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Zhao J and Guo W: Emotional roles of mono-aminergic neurotransmitters in major depressive disorder and anxiety disorders. Front Psychol. 9(2201)2018.PubMed/NCBI View Article : Google Scholar | |
|
Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C and Lindefors N: Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Transl Psychiatry. 2(e120)2012.PubMed/NCBI View Article : Google Scholar | |
|
Pöldinger W, Calanchini B and Schwarz W: A functional-dimensional approach to depression: Serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology. 24:53–81. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Bromberg-Martin ES, Matsumoto M and Hikosaka O: Dopamine in motivational control: Rewarding, aversive, and alerting. Neuron. 68:815–834. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Olguín HJ, Guzmán DC, García EH and Mejía GB: The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid Med Cell Longev. 2016(9730467)2016.PubMed/NCBI View Article : Google Scholar | |
|
Moret C and Briley M: The importance of norepinephrine in depression. Neuropsychiatr Dis Treat. 7 (Suppl 1):S9–S13. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Coppen A: The biochemistry of affective disorders. Br J Psychiatry. 113:1237–1264. 1967.PubMed/NCBI View Article : Google Scholar | |
|
Cowen PJ and Browning M: What has serotonin to do with depression? World Psychiatry. 14:158–160. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Pivonello R, De Leo M, Cozzolino A and Colao A: The treatment of cushing's disease. Endocr Rev. 36:385–486. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Nandam LS, Brazel M, Zhou M and Jhaveri DJ: Cortisol and major depressive disorder-translating findings from humans to animal models and back. Front Psychiatry. 10(974)2020.PubMed/NCBI View Article : Google Scholar | |
|
Juruena MF, Agustini B, Cleare AJ and Young AH: A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling. Stem Cell Investig. 4(13)2017.PubMed/NCBI View Article : Google Scholar | |
|
Delaveau P, Jabourian M, Lemogne C, Guionnet S, Bergouignan L and Fossati P: Brain effects of antidepressants in major depression: A meta-analysis of emotional processing studies. J Affect Disord. 130:66–74. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Yan HC, Cao X, Gao TM and Zhu XH: Promoting adult hippocampal neurogenesis: A novel strategy for antidepressant drug screening. Curr Med Chem. 18:4359–4367. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Dranovsky A and Hen R: Hippocampal neurogenesis: Regulation by stress and antidepressants. Biol Psychiatry. 59:1136–1143. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wagner G, Koch K, Schachtzabel C, Sobanski T, Reichenbach JR, Sauer H and Schlösser RG: Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. J Psychiatry Neurosci. 35:247–257. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Andrade C and Rao NS: How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian J Psychiatry. 52:378–386. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Trifu S, Carp EG and Nadoleanu A: Alcohol as a substitute, mask of depression and ‘antidote’ of narcissism. Eur Proc Soc Behav Sci. 31:986–994. 2017. | |
|
Magariños AM, Deslandes A and McEwen BS: Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress. Eur J Pharmacol. 371:113–122. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A and Gennarelli M: Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int J Neuropsychopharmacol. 13:103–108. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, et al: Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 301:805–809. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Nestler EJ and Carlezon WA Jr: The mesolimbic dopamine reward circuit in depression. Biol Psychiatry. 59:1151–1159. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Watanabe Y, Gould E, Daniels DC, Cameron H and McEwen BS: Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol. 222:157–162. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G and Popoli M: Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci. 25:3270–3279. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Malberg JE, Eisch AJ, Nestler EJ and Duman RS: Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 20:9104–9110. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Rocher C, Spedding M, Munoz C and Jay TM: Acute stress-induced changes in hippocampal/prefrontal circuits in rats: Effects of antidepressants. Cereb Cortex. 14:224–229. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Newport DJ, Carpenter LL, McDonald WM, Potash JB, Tohen M and Nemeroff CB: APA Council of Research Task Force on Novel Biomarkers and Treatments. Ketamine and other NMDA antagonists: Early clinical trials and possible mechanisms in depression. Am J Psychiatry. 172:950–966. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Hayley S and Litteljohn D: Neuroplasticity and the next wave of antidepressant strategies. Front Cell Neurosci. 7(218)2013.PubMed/NCBI View Article : Google Scholar | |
|
Gigliucci V, O'Dowd G, Casey S, Egan D, Gibney S and Harkin A: Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology (Berl). 228:157–166. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Tan S, Lam WP, Wai MS, Yu WH and Yew DT: Chronic ketamine administration modulates midbrain dopamine system in mice. PLoS One. 7(e43947)2012.PubMed/NCBI View Article : Google Scholar | |
|
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G and Duman RS: mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 329:959–964. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Loo C, Simpson B and MacPherson R: Augmentation strategies in electroconvulsive therapy. J ECT. 26:202–207. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Singh A and Kar SK: How electroconvulsive therapy works?: Understanding the neurobiological mechanisms. Clin Psychopharmacol Neurosci. 15:210–221. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Cano M, Cardoner N, Urretavizcaya M, Martínez-Zalacaín I, Goldberg X, Via E, Contreras-Rodríguez O, Camprodon J, de Arriba-Arnau A, Hernández-Ribas R, et al: Modulation of limbic and prefrontal connectivity by electroconvulsive therapy in treatment-resistant depression: A preliminary study. Brain Stimul. 9:65–71. 2016.PubMed/NCBI View Article : Google Scholar |
